Michael Milligan Lee's most recent trade in Neumora Therapeutics Inc. was a trade of 400,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 400,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 85,391 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 85,391 | 85,391 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 41,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 41,250 | 41,250 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 38,234 | 38,234 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 38,234 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 28,675 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 28,675 | 28,675 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Sale of securities on an exchange or to another person at price $ 1.69 per share. | 18 Feb 2025 | 1,978 | 22,470 | - | 1.7 | 3,351 | Common Stock |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 85,391 | 85,391 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 85,391 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 41,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 41,250 | 41,250 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 38,234 | 38,234 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 38,234 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 28,675 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Lee Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 28,675 | 28,675 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Lee Michael Milligan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 41,250 | 41,250 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Michael Milligan Lee | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 20,625 | 24,448 | - | 0 | Common Stock |